SignalCorporate
ELI LILLY CEO TELLS CNBC ONE-THIRD OF NEW GLP-1 PILL PATIENTS ARE TAKING FOUNDAYO, AS DRUGMAKER RAMPS UP PRODUCTION - CNBC
Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up.
What changed
Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up.
Why it matters
Eli Lilly CEO reports one-third of new GLP-1 pill patients on Foundayo amid production ramp-up. — impact context not separately stored; see What changed.